Medtronic’s Ishrak: Europe slow to adopt renal denervation | Wall Street Beat May 10, 2013 By Brad Perriello Leave a Comment Medtronic (NYSE:MDT) CEO Omar Ishrak said low reimbursement rates and a lack of understanding of the technology have hampered the uptake of renal denervation for high blood pressure in Europe.